Nuveen Asset Management, LLC - TRANSLATE BIO INC ownership

TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 61 filers reported holding TRANSLATE BIO INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$9,133,000
+2.1%
331,621
-38.9%
0.00%0.0%
Q1 2021$8,948,000
-10.9%
542,649
-0.4%
0.00%0.0%
Q4 2020$10,043,000
+32.8%
544,935
-1.9%
0.00%0.0%
Q3 2020$7,564,000
+95.6%
555,771
+157.5%
0.00%
+50.0%
Q2 2020$3,867,000
+180.0%
215,810
+55.8%
0.00%
+100.0%
Q1 2020$1,381,000
+44.2%
138,522
+17.7%
0.00%
Q4 2019$958,000
-18.0%
117,667
-0.3%
0.00%
Q3 2019$1,169,000
-21.0%
118,002
+0.7%
0.00%
-100.0%
Q2 2019$1,479,000117,1440.00%
Other shareholders
TRANSLATE BIO INC shareholders Q2 2019
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 3,922,008$39,102,00052.94%
Omega Fund Management, LLC 2,437,603$24,303,00010.06%
Baupost Group 17,544,239$171,071,0002.52%
FRAZIER MANAGEMENT LLC 2,182,789$21,762,0002.47%
RTW INVESTMENTS, LP 3,692,424$36,813,0001.58%
Camber Capital Management LP 1,765,000$17,597,0001.05%
Bain Capital Public Equity Management II, LLC 416,670$4,154,0000.49%
Rock Springs Capital Management LP 825,000$8,225,0000.34%
Birchview Capital, LP 30,000$299,0000.26%
Artal Group S.A. 600,000$5,982,0000.25%
View complete list of TRANSLATE BIO INC shareholders